Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 2
2008 1
2009 1
2010 2
2011 2
2013 3
2014 1
2015 1
2016 3
2017 3
2018 1
2019 8
2020 5
2021 4
2022 6
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L. Guillo L, et al. Among authors: haemel ak. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):254-261. doi: 10.1016/S2468-1253(21)00297-1. Epub 2022 Jan 17. Lancet Gastroenterol Hepatol. 2022. PMID: 35051383
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group; Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group. Ferdowsi N, et al. Ann Rheum Dis. 2019 Jun;78(6):807-816. doi: 10.1136/annrheumdis-2018-214764. Epub 2019 Mar 30. Ann Rheum Dis. 2019. PMID: 30928903
Telangiectases in Systemic Sclerosis.
Jacobson R, Agnihothri R, Haemel A. Jacobson R, et al. Among authors: haemel a. JAMA Dermatol. 2021 Apr 1;157(4):457. doi: 10.1001/jamadermatol.2020.4831. JAMA Dermatol. 2021. PMID: 33595597 No abstract available.
Widespread Erythematous Plaques With Prominent Telangiectases.
Kusari A, LeBoit PE, Haemel A. Kusari A, et al. Among authors: haemel a. JAMA Dermatol. 2021 Nov 1;157(11):1376-1377. doi: 10.1001/jamadermatol.2021.4068. JAMA Dermatol. 2021. PMID: 34643657 No abstract available.
Recurrent breast cellulitis from a nipple fissure.
Pimentel MA, Haemel AK. Pimentel MA, et al. Among authors: haemel ak. JAAD Case Rep. 2018 Mar 2;4(3):251-252. doi: 10.1016/j.jdcr.2018.01.014. eCollection 2018 Apr. JAAD Case Rep. 2018. PMID: 29687063 Free PMC article. No abstract available.
50 results